Search research articles
Contact Us
Filters
Showing results (81-90 of 152) with videos related to
Page
of 16
Sort By:
Melanoma Research
|
October 24, 2002
Clinical evaluation of 5-S-cysteinyldopa testing using a new and optimized detection system as a tumour marker for malignant melanoma
T Meyer, A Hauschild, A Kromminga, et al.
The British Journal of Dermatology
|
September 25, 2009
Certification of sun protection practices in a German child day-care centre improves children's sun protection--the 'SunPass' pilot study
W Aulbert, C Parpart, R Schulz-Hornbostel, et al.
The British Journal of Dermatology
|
August 10, 2011
Evaluation of Bowen disease by in vivo reflectance confocal microscopy
M Ulrich, J Kanitakis, S González, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
September 2, 2014
Long-term sustained lesion clearance from Lmax with imiquimod 3.75%, a new field-directed treatment for actinic keratosis
G Gupta, E Stockfleth, K Peris, et al.
The British Journal of Dermatology
|
March 28, 2008
Topical Polyphenon E in the treatment of external genital and perianal warts: a randomized controlled trial
E Stockfleth, H Beti, R Orasan, et al.
The British Journal of Dermatology
|
March 27, 2007
Multifocal distribution of cutaneous human papillomavirus types in hairs from different skin areas
A Köhler, T Forschner, T Meyer, et al.
The British Journal of Dermatology
|
May 10, 2007
Treatment of multiple actinic keratoses with topical diclofenac 3% gel in organ transplant recipients: a series of six cases
C Ulrich, M Hackethal, M Ulrich, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
August 26, 2015
Imiquimod 3.75% in actinic keratosis: efficacy in patients with and without rest periods during treatment
T Dirschka, K Peris, G Gupta, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
October 30, 2014
Efficacy of imiquimod 3.75% from Lmax according to the number of actinic keratosis lesions
K Peris, E Stockfleth, G Gupta, et al.
The British Journal of Dermatology
|
November 9, 2000
Self-administered topical 5% imiquimod for the treatment of common warts and molluscum contagiosum
U R Hengge, S Esser, T Schultewolter, et al.
Page
of 16
Search research articles
Search
Showing results (81-90 of 152) with videos related to
Sort By:
Page
of 16
Melanoma Research
|
October 24, 2002
Clinical evaluation of 5-S-cysteinyldopa testing using a new and optimized detection system as a tumour marker for malignant melanoma
T Meyer, A Hauschild, A Kromminga, et al.
The British Journal of Dermatology
|
September 25, 2009
Certification of sun protection practices in a German child day-care centre improves children's sun protection--the 'SunPass' pilot study
W Aulbert, C Parpart, R Schulz-Hornbostel, et al.
The British Journal of Dermatology
|
August 10, 2011
Evaluation of Bowen disease by in vivo reflectance confocal microscopy
M Ulrich, J Kanitakis, S González, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
September 2, 2014
Long-term sustained lesion clearance from Lmax with imiquimod 3.75%, a new field-directed treatment for actinic keratosis
G Gupta, E Stockfleth, K Peris, et al.
The British Journal of Dermatology
|
March 28, 2008
Topical Polyphenon E in the treatment of external genital and perianal warts: a randomized controlled trial
E Stockfleth, H Beti, R Orasan, et al.
The British Journal of Dermatology
|
March 27, 2007
Multifocal distribution of cutaneous human papillomavirus types in hairs from different skin areas
A Köhler, T Forschner, T Meyer, et al.
The British Journal of Dermatology
|
May 10, 2007
Treatment of multiple actinic keratoses with topical diclofenac 3% gel in organ transplant recipients: a series of six cases
C Ulrich, M Hackethal, M Ulrich, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
August 26, 2015
Imiquimod 3.75% in actinic keratosis: efficacy in patients with and without rest periods during treatment
T Dirschka, K Peris, G Gupta, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
October 30, 2014
Efficacy of imiquimod 3.75% from Lmax according to the number of actinic keratosis lesions
K Peris, E Stockfleth, G Gupta, et al.
The British Journal of Dermatology
|
November 9, 2000
Self-administered topical 5% imiquimod for the treatment of common warts and molluscum contagiosum
U R Hengge, S Esser, T Schultewolter, et al.
Page
of 16